Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil
Observational Study
[키워드] 95% CI
addition
baseline
Brazil
Chi-square
chronic
clinical
Community
confounders
Control
COVID-19
COVID-19 diagnosis
COVID-19 symptoms
criteria
cross-sectional analysis
defined
demographic data
Diagnosis
disease
enrolled
Enrollment
epidemiological
Fisher test
flu
glucocorticoid
Hydroxychloroquine
Hydroxycloroquine
individual
Influenza
information
lack
large cohort
Lung disease
Ministry of Health
Model
no significant difference
occurrence of COVID-19
outbreak
participant
Patient
patients
physician
PROTECT
protective effect
protective role
registry
Regression
reported
Result
rheumatic disease
Rheumatic diseases
rheumatoid arthritis
risk factor
SARS-COV-2 infection
significantly
Sjögren’s syndrome
statistical analysis
Symptom
systemic erythematosus lupus
Systemic sclerosis
the SARS-CoV-2
use of hydroxychloroquine
vaccination
Viral transmission
Wald test
web-based platform
were recorded
were used
[DOI] 10.1186/s42358-021-00217-0 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s42358-021-00217-0 PMC 바로가기 [Article Type] Observational Study